ESPR icon

Esperion Therapeutics

139 hedge funds and large institutions have $299M invested in Esperion Therapeutics in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

12.7% less ownership

Funds ownership: 100.53%87.84% (-13%)

19% less call options, than puts

Call options by funds: $9.22M | Put options by funds: $11.4M

50% less capital invested

Capital invested by funds: $598M → $299M (-$299M)

Holders
139
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.22M
Puts
$11.4M
Net Calls
Net Calls Change

Top Buyers

1 +$3.06M
2 +$2.31M
3 +$2.23M
4
CS
Credit Suisse
Switzerland
+$1.92M
5
Millennium Management
Millennium Management
New York
+$1.81M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$573K
52
$509K
53
$501K
54
$447K
55
$419K
56
$418K
57
$416K
58
$414K
59
$403K
60
$381K
61
$369K
62
$356K
63
$344K
64
$332K
65
$326K
66
$316K
67
$285K
68
$278K
69
$271K
70
$270K
71
$246K
72
$239K
73
$229K
74
$219K
75
$214K